Assort Health Secures $102 Million Funding
assort Health Secures $102 Million to Revolutionize Patient Access with AI
Here’s a summary of the key information from the provided text:
What: Assort Health, a company developing an “agentic AI platform” to improve patient access and experience, has secured $102 million in funding.
who: The funding round included participation from First Round Capital, Chemistry, A*, Liquid2, and Quite Capital.Lightspeed Venture partners partner Galym Imanbayev will join the board, and Paul Ricci (founding CEO of Nuance) will join as a board advisor.
Founders: Jeff Liu and Jon Wang are the founders and co-CEOs of Assort Health.
What they do: Assort Health aims to solve the frustrating process of scheduling doctor’s appointments and improve the overall patient experience. Thier platform, Assort OS, handles tasks beyond scheduling, including care navigation, lab tests, prescription renewals, and physician referrals. They’ve already processed tens of millions of patient interactions across thousands of providers.
The problem: The current system for scheduling appointments is often inefficient and frustrating,involving long hold times,transfers,and data repetition. U.S. adults spend the equivalent of a workday each month navigating healthcare needs.
Key Highlights:
* Agentic AI: Assort Health leverages agentic AI to streamline patient engagement.
* Fast-Paced Culture: The company boasts a highly productive engineering team, operating at the 100th percentile in velocity.
* Investor Support: Apolo Ohno, eight-time Olympic champion, is an investor and highlights the company’s focus on patient experience.
* Addressing Provider Challenges: Assort Health also aims to help providers facing reduced reimbursements, rising costs, and staff shortages by streamlining front office operations.